We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 830 results
  1. Advances in Vaccine Adjuvants: Nanomaterials and Small Molecules

    Adjuvants have been extensively and essentially formulated in subunits and certain inactivated vaccines for enhancing and prolonging protective...
    Bingbing Sun, Min Li, ... Yubin Ma in Drug Delivery and Targeting
    Chapter 2023
  2. Behaviour and associated determinants of COVID-19 vaccine acceptance and advocacy: a nationwide survey of pharmacy professionals in Qatar

    Background

    Vaccine hesitancy poses a global challenge and is acknowledged to be a complex, multifactorial phenomenon. Of particular concern is...

    Moza Al Hail, Pallivalapila Abdulrouf, ... Binny Thomas in Journal of Pharmaceutical Policy and Practice
    Article Open access 28 November 2023
  3. Exploring determinants of community pharmacist-led influenza vaccination in a Middle Eastern country: a national web-based cross-sectional study

    Background

    Utilizing community pharmacists (CPs) as immunizers has being adopted in various countries as approach to boost influenza vaccination...

    Dalal Youssef, Linda Abou-Abbas, Hamad Hassan in Journal of Pharmaceutical Policy and Practice
    Article Open access 20 September 2021
  4. Practice of non-pharmaceutical interventions against COVID-19 and reduction of the risk of influenza-like illness: a cross-sectional population-based study

    Introduction

    While the widespread implementation of the non-pharmaceutical interventions was intended to contain the COVID-19 pandemic, such measures...

    Dalal Youssef, Ola Issa, ... Edmond Abboud in Journal of Pharmaceutical Policy and Practice
    Article Open access 30 August 2022
  5. Validation Studies of Some Stages of Drug Production from Equine Blood Plasma Regarding the Reduction of Extraneous Viruses

    Russian and foreign pharmacopoeias require at least two stages in the manufacturing process of medicinal products based on animal serum-plasma to...

    V. V. Mashin, A. N. Sergeev, ... N. V. Zagidullin in Pharmaceutical Chemistry Journal
    Article 01 March 2024
  6. Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives

    Background

    People with weakened immune systems may not develop adequate protection after taking two doses of the mRNA-combined COVID-19 vaccine. The...

    Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, ... Zaheer-Ud-Din Babar in Journal of Pharmaceutical Policy and Practice
    Article Open access 28 March 2022
  7. Economic Evidence for Pharmacist-Led Vaccination Services

    Vaccination is one of the most successful and cost-effective public health interventions of all time. Despite the existence of safe and efficacious...
    Reference work entry 2023
  8. Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus

    The SARS-CoV-2 outbreak has posed a plethora of problems for the global healthcare system and socioeconomic burden. Despite valiant efforts to...

    Arbind Kumar, Aashish Sharma, ... Sanjay Kumar in Pharmacological Reports
    Article 20 September 2022
  9. Community pharmacist-administered seasonal influenza vaccination: a national customer survey

    Background

    In Switzerland, the influenza vaccination is recommended for high-risk groups and people who have contact with high-risk groups. Since...

    Dominik Stämpfli, Adrian Martinez-De la Torre, ... Andrea M. Burden in Journal of Pharmaceutical Policy and Practice
    Article Open access 25 September 2020
  10. Assessment of COVID-19 vaccines acceptance in the Lebanese population: a national cross-sectional study

    Background

    Vaccines have become the best weapon for epidemic prevention and control in the absence of standard approved effective therapies. However,...

    Philippe Hanna, Aline Issa, ... Nadine Saleh in Journal of Pharmaceutical Policy and Practice
    Article Open access 11 January 2022
  11. Immunization Practice in Low- and Middle-Income Countries

    Immunization is the cornerstone management approach for preventing children, adolescents, adults, and susceptible people from vaccine-preventable...
    Asmita Priyadarshini Khatiwada, Sunil Shrestha, ... Binaya Sapkota in Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy
    Reference work entry 2023
  12. Pharmacist-led vaccination services in the Middle East

    Successful Vaccine uptake relies heavily on the effectiveness of vaccination services. Expanding the scope of pharmacists’ involvement in vaccination...

    Faten Naif Aldajani, Mohammed Aldosari in Journal of Pharmaceutical Policy and Practice
    Article Open access 29 December 2023
  13. Evidence of the Impact of Pharmacists Through Immunization Interventions

    In light of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic, research into the most effective and efficient ways to roll...
    Reference work entry 2023
  14. State capture through indemnification demands? Effects on equity in the global distribution of COVID-19 vaccines

    Background

    State capture by the pharmaceutical industry is a form of corruption whereby pharmaceutical companies shift laws or policies about their...

    Ariel Gorodensky, Jillian C. Kohler in Journal of Pharmaceutical Policy and Practice
    Article Open access 19 August 2022
  15. A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study

    Background

    Since the deployment of Coronavirus Disease 2019 (COVID-19) vaccines, skepticism about the safety, incidence, and severity of Adverse...

    Abeer Zeitoun, Souheil Hallit, ... Rita Karam in Journal of Pharmaceutical Policy and Practice
    Article Open access 21 February 2023
  16. Alternative New Mono-scaled Quantitative Benefit–Risk Assessment of Human Papillomavirus Vaccine in Japan

    Background

    The human papillomavirus (HPV) vaccine coverage is very low in Japan since the government suspended the active encouragement of the...

    Tomoko Matsumoto, Naoki Matsumaru, ... Katsura Tsukamoto in Therapeutic Innovation & Regulatory Science
    Article 22 June 2020
  17. mRNA vaccines: the most recent clinical applications of synthetic mRNA

    Synthetic mRNA has been considered as an emerging biotherapeutic agent for the past decades. Recently, the SARS-CoV-2 pandemic has led to the first...

    Suji Kwon, Minseon Kwon, ... Hyuk** Lee in Archives of Pharmacal Research
    Article 15 April 2022
  18. Why COVID vaccines for young children (5–11 years) are not essential at this moment in time?

    The Joint Committee on Vaccination and Immunisation (JCVI) in UK has recently advised that COVID vaccines in 5–11-year-old children is non-essential....

    Article Open access 28 March 2022
  19. Cost-effectiveness analysis of current non-mandatory hepatitis B vaccination coverage vs expanding coverage among healthcare workers in Ethiopia

    Background

    Ethiopia is a country with high endemicity in Hepatitis B (HepB) virus infection. However, only 14% of healthcare workers (HCWs) are...

    Dinksew Tewuhibo, Getahun Asmamaw, Wondim Ayenew in Journal of Pharmaceutical Policy and Practice
    Article Open access 17 October 2022
  20. Economic Evidence for Pharmacist Prescribing in Community Pharmacy

    The effectiveness of pharmacist interventions is supported by high-level evidence from around the world. Such effectiveness combined with high levels...
    Reference work entry 2023
Did you find what you were looking for? Share feedback.